Cardiovascular events prior to or early after diagnosis of systemic lupus erythematosus in the systemic lupus international collaborating clinics cohort
暂无分享,去创建一个
I. Bruce | D. Gladman | M. Urowitz | E. Ginzler | C. Gordon | J. Hanly | D. Isenberg | K. Kalunian | O. Nived | M. Petri | J. Sánchez-Guerrero | G. Sturfelt | M. Urowitz | G. Alarcón | S. Bae | G. Sturfelt | S. Bernatsky | K. Steinsson | M. Khamashta | D. Wallace | G. Ruiz-Irastorza | D. Kamen | M. Inanç | J. Merrill | S. Manzi | R. Ramsey‐Goldman | D. Kamen | M. Ramos-Casals | A. Clarke | P. Fortin | C. Peschken | J. Hanly | Anisur Rahman | M. Khamashta | N. Anderson | R. Vollenhoven | A. Zoma | T. Stoll | S. Jacobsen | C. Aranow | J. Romero-Diaz | E. Ginzler | D. Gladman | M. Dooley | A. Rahman | A. Clarke | J. Su | J. Merrill | B. Fessler | S. Lim | R. van Vollenhoven | A. Askanase | S. Bernatsky | A. Zoma | J. Su | I. Bruce | S. Bae | J. Romero-Díaz | P. Fortin | G. Ruiz‐Irastorza | Daniel J. Wallace | R. V. Vollenhoven
[1] R. Chang,et al. Is preclinical autoimmunity benign?: The case of cardiovascular disease. , 2014, Rheumatic diseases clinics of North America.
[2] M. Brown,et al. Cardiovascular disease is increased prior to onset of rheumatoid arthritis but not osteoarthritis: the population-based Nord-Trøndelag health study (HUNT) , 2014, Arthritis Research & Therapy.
[3] Christie M. Bartels,et al. Mortality and Cardiovascular Burden of Systemic Lupus Erythematosus in a US Population-based Cohort , 2014, The Journal of Rheumatology.
[4] J. Aviña-Zubieta,et al. Overall and Cause‐Specific Mortality in Patients With Systemic Lupus Erythematosus: A Meta‐Analysis of Observational Studies , 2014, Arthritis care & research.
[5] C. Bennett,et al. Ascertainment of chronic diseases using population health data: a comparison of health administrative data and patient self-report , 2013, BMC Public Health.
[6] D. Gladman,et al. Epidemiology of atherosclerosis in systemic lupus erythematosus , 2009, Current rheumatology reports.
[7] K. Ley,et al. Immune and inflammatory mechanisms of atherosclerosis (*). , 2009, Annual review of immunology.
[8] B. Tom,et al. Cardiovascular morbidity in psoriatic arthritis , 2008, Annals of the rheumatic diseases.
[9] B. Tom,et al. Changing Patterns in Mortality and Disease Outcomes for Patients with Systemic Lupus Erythematosus , 2008, The Journal of Rheumatology.
[10] I. Bruce,et al. Accumulation of coronary artery disease risk factors over three years: data from an international inception cohort. , 2008, Arthritis and rheumatism.
[11] D. Gladman,et al. Atherosclerosis and Lupus — The SLICC study , 2007, Lupus.
[12] I. Bruce,et al. Clinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: data from an international inception cohort , 2007, Lupus.
[13] Javier Martín,et al. High prevalence of subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. , 2007, Arthritis and rheumatism.
[14] Fred S Apple,et al. Universal definition of myocardial infarction. , 2007, Journal of the American College of Cardiology.
[15] J. Tu,et al. Regional variation in self-reported heart disease prevalence in Canada. , 2005, The Canadian journal of cardiology.
[16] S. Gabriel,et al. Cardiovascular death in rheumatoid arthritis: a population-based study. , 2005, Arthritis and rheumatism.
[17] R Hal Scofield,et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. , 2003, The New England journal of medicine.
[18] M. Abrahamowicz,et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. , 2001, Arthritis and rheumatism.
[19] I. Bruce,et al. Premature atherosclerosis in systemic lupus erythematosus. , 2000, Rheumatic diseases clinics of North America.
[20] I. Bruce,et al. Natural history of hypercholesterolemia in systemic lupus erythematosus. , 1999, The Journal of rheumatology.
[21] M. Ward. Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus. , 1999, Arthritis and rheumatism.
[22] R. D'Agostino,et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. , 1997, American journal of epidemiology.
[23] D. Gladman,et al. Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death. , 1995, The Journal of rheumatology.
[24] H. Tunstall-Pedoe,et al. Myocardial Infarction and Coronary Deaths in the World Health Organization MONICA Project: Registration Procedures, Event Rates, and Case‐Fatality Rates in 38 Populations From 21 Countries in Four Continents , 1994, Circulation.
[25] M. Petri,et al. Risk factors for coronary artery disease in patients with systemic lupus erythematosus. , 1992, The American journal of medicine.
[26] J F Fries,et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.
[27] M. Urowitz,et al. The bimodal mortality pattern of systemic lupus erythematosus. , 1976, The American journal of medicine.